跳至主要内容
临床试验/NCT03516461
NCT03516461招募中不适用

Efficacy and Safety of Fecal Microbiota Transplantation in Radiation Enteritis

The Second Hospital of Nanjing Medical University1 个研究点 分布在 1 个国家目标入组 70 人开始时间: 2018年1月7日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
70
试验地点
1
主要终点
Clinical response rate

研究概览

简要总结

Radiation enteritis is one of the most feared complications after abdominal or pelvic radiation therapy.The gut microbiota is considered to constitute a "microbial organ" which has pivotal roles in the intestinal diseases and body metabolism. Evidence from animal studies demonstrated the link between intestinal bacteria and radiation enteritis. This clinical trial aims to evaluate the efficacy and safety of fecal microbiota transplantation (FMT) for radiation enteritis.

详细描述

The present clinical trial aims to re-establish a gut functionality state of intestinal microbiota through fecal microbiota transplantation (FMT) for radiation enteritis (RE). FMT is the whole profile of fecal microbiota transplantation. At enrollment, "Shared Decision Making" intervention was applied to support patient involvement in making health decisions. Patients have opportunity to choose fecal microbiota transplantation (FMT). Patients will receive follow-up for at least 12 weeks. Blood test, endoscopy and questionnaire will be used to access participants at study start and at study completion. Fecal microbiota compositions, blood and urinary metabolic profiles of patients will be analyzed to assess associated microbial changes.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • age ≥18 years old;
  • Radiation enteritis diagnosed by colonoscopy after finishing radiotherapy.

排除标准

  • Patients who were pregnant or nursing;
  • Patients who were unable or unwilling to undergo a gastroscopy;
  • Patients who had gastrointestinal infection;
  • Patients with cardiopulmonary failure.

研究组 & 干预措施

Basic treatment

No Intervention

Patient receives basic therapy for RE during hospitalization

Fecal Microbiota Transplantation (FMT)

Experimental

Patients receive a course of FMT during hospitalization

干预措施: Fecal Microbiota Transplantation (FMT) (Procedure)

结局指标

主要结局

Clinical response rate

时间窗: 12 weeks

The clinical response rate at 8 weeks after fmt treatment

次要结局

  • Scores of gastrointestinal symptoms(4, 8, 12 weeks)
  • Change of toxicity grade(4, 8, 12 weeks)

研究者

发起方
The Second Hospital of Nanjing Medical University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Faming Zhang

Professor, Microbiota Medicine, Gastroenterology

The Second Hospital of Nanjing Medical University

研究点 (1)

Loading locations...

相似试验